ABSTRACT. Formation of platelet-producing megakaryocytes, the cytoplasm of which showed the terminal stage of cell maturation, heavy granulation and platelet-fields delineated with demarcation membranes, was observed in a short-term culture system, using megakaryocyte-enriched bone marrowcell suspension. Approximately 6-8% of the megakaryocytes changed to the platelet-producing megakaryocytes during 12-hour incubation. In the presence of inhibitors of energy metabolism, formation of the platelet-producing megakaryocytes was inhibited, suggesting that the process is dependent on energy producing systems. Ganglioside GDla increased both the number of total megakaryocytes and the ratio of the platelet-producing megakaryocytes to total megakaryocytes, while GM1did not influence the number of total megakaryocytes, but increased the ratio.
Glycosphingolipids of animal cells are located in the plasma membrane, and play roles in a variety of cellular events, including growth and differentiation (3) . Considerable evidence suggests that glycosphingolipids exogenously added to cell culture mediumare incorporated into the plasma membrane, and function as well as those synthesized in situ (3, 5, 6, 7, 15) . Nojiri et al. demonstrated that ganglioside GM3 characteristically increased during macrophage-like cell differentiation of human promyelocytic leukemia cell line HL-60 (ll).
They further proved that exogenous ganglioside GM3 was highly potent for differentiation-induction of the same cell line along a monocytic lineage (12) . It is conceivable that exogenous ganglioside molecular species that specifically stimulate cell differentiation or maturation in culture system could be characteristic molecules which are synthesized in the cells and play roles in processes of cell differentiation and maturation.
The process of megakaryocyte maturation before platelet-shedding involves 1) the cytoplasmic growth with acquisition of platelet-specific proteins, such as acetylcholinesterase in rodent megakaryocytes, and 2) the organization of the platelet specific organelles into "platelet fields" by demarcation membranes. In our laboratory, potentiation of murine megakaryocytopoiesis by ganglioside GDIa was demonstrated during 7-day incubation in a liquid culture system (19). Ganglioside
GDIa appeared to be one of molecular species that induce megakaryocytic maturation. In the present study, the effects of ganglioside GDIa and the other ganglioside series on the terminal steps of the cell maturation of murine megakaryocytes were examined in a shorttermculture system.
MATERIALS AND METHODS
Gangliosides from bovine brain (Sigma Type II), GM1, GDIa, nueraminidase from Clostridium perfringens (Sigma Type X-A) and protease from Streptomyces griseus were purchased from Sigma Chemical Company, USA, and gangliosides GM2,GM3and GDlb from Iatron Laboratories, Inc., Japan. BDFi female mice (6 weeks old, Shizuoka Laboratory Animal Center, Japan) were employed in all studies.
Bonemarrowcell collection and megakaryocyteenrichment and cell culture were carried out essentially according to the method of Handagama et al. (4) . The RPMI 1640 culture medium with 0.38% sodium citrate, 15% fetal calf serum (FCS, Flow Laboratories), 500 U of penicillin/ml and 50 jug of streptomycin/ml was used to make a colloidal Percoll (Pharmacia) solution of 1.050 g/ml density. The solution was used to flush out, as well as to suspend, the bone marrow cells for density gradient centrifugation.
The suspension was placed in polypropylene tubes. This was overlayered with the RPMI 1640 medium which contained 0.38% citric acid and 15% FCS. The tubes were centrifuged in a swingout rotor at 1,000
x g for 30 min at room temperature. The low-density band of cells at the upper interface (megakaryocyte-enriched fraction) was used.
Ten ju\ of the megakaryocyte-enriched fraction was placed into a chamber, which was constructed by sealing with grease a glass slide and a plastic sheet (0.2 mmthick) through which 2 holes (9 mmdiameter) were cut. The glass surface of the chamber was coated with polylysine. Addition of 10 jul of the megakaryocyte-enriched cell suspension resulted in the seeding of approximately 30 to 70 megakaryocytes/chamber.
Control cultures consisted of the megakaryocyte-enriched fraction diluted with an equal volume of the incubation medium, which consisted of RPMI 1640 medium with 15% FCS, 500 U of penicillin/ml and 50 jug streptomycin/ml. In test culture, various metabolic inhibitors and gangliosides were added in appropriate concentrations to the incubation medium before mixing with the megakaryocyte-enriched fraction. The chambers were covered with cover glasses and incubation was done at 37°C with 5% CO2-95% air. Megakaryocytes were readily identified by their large size under a phase-contrast microscope. With incubation time, fragmentation of megakaryocytecytoplasmwasobserved. These megakaryocytes with fragmented cytoplasm were defined as platelet-producing megakaryocytes. Megakaryocytes and the platelet-producing megakaryocytes in culture chambers were counted and the ratio of the platelet-producing megakaryocytes to total megakaryocytes was calculated.
Treatment of ganglioside preparations with neuraminidase was carried out as follows. Neuraminidase suspension (insoluble enzyme attached to beaded agarose, suspended in 2.0 M (NH4)2SO4, pH 7.0) in a volume of 0.325 ml (0.125 units) was centrifuged at 7,000 rpm for 5 min (Eppendorf centrifuge 5414S) at 4°C, and the supernatant was removed. The pellet was washed twice with 0.3 ml of 0.1 Mphosphate buffer (pH 6.5) by centrifugation under the same conditions as described above. To the washed pellet, 0.25 ml of a ganglioside solution (2 mg/ml 0.1 Mphosphate buffer, pH 6.5) was added and the suspended mixture was incubated for 4 min at 37°C. The reaction was terminated by cooling the mixture in an ice-water bath for 2 min, and then the mixture was centrifuged at 7,000 rpm for 5 min at 4°C. The supernatant was used as neuraminidase-treated ganglioside. For treatment with protease, the protease preparation (0.125 units, insoluble enzymeattached to cross-linked beaded agarose, lyophilized powder, stabilized with lactose) was washed once with 0.1 Mphosphate buffer (pH 7.0) by centrifugation, and to the pellet, a ganglioside solution (2mg/ml, in 0.1 M phosphate buffer, pH 7.0) was added, and the suspended mixture was incubated for 4 min at 30°C. Centrifugation was carried out at 7,000 rpm. The supernatant was used as protease-treated ganglioside. formation of platelet demarcation membranes (Fig. 2) . Figure 3 shows time-course of formation of the platelet-producing megakaryocytes in the culture system. In control system, the number of total megakaryocytes decreased slightly and reached a plateau level of approximately 70%of the number at the start of incubation. The platelet-producing megakaryocytes were not seen at the start of incubation. With incubation time, the platelet-producing megakaryocytes appeared and increased (Fig. 3B) . The ratio of the platelet-producing megakaryocytes to total megakaryocytes increased markedly during the initial 3 hours and then gradually, and at a later phase, maintained a plateau level during 24-hour incubation. The number of the platelet-producing megakaryocytes amounted to approximately 1% of the number of total megakaryocytes at 12-hour incubation (Fig. 3C) . When bovine brain ganglioside mixture was added to the culture medium,an increase after a transient decrease in the number of total megakaryocytes was observed. The numberof total megakaryocytes reached a maximumlevel at 12-hour incubation and then decreased (Fig. 3A) . The number of the platelet-producing megakaryocytes also increased with incubation time and reached a maximumvalue (Fig.  3B) . The ratio of the platelet-producing megakaryocytes to total megakaryocytes amounted to approximately 12%, suggesting the stimulation of platelet-producing megakaryocyte formation by the ganglioside mixture (Fig. 3C ).
In the presence of KCN, NaF or monoiodoacetic acid, the ratio of the platelet-producing megakaryocytes to total megakaryocytes markedly decreased ( Fig.   4B ), although the number of total megakaryocytes also showed a tendency to decrease by these inhibitors (Fig.   4A ). The results suggest that the formation of the platelet-producing megakaryocytes is dependent on the energy-producing systems.
In order to examinethe effects of various gangliosides on the cytoplasmic maturation, the megakaryocyte-enriched bone marrow cell suspension was incubated for 12 hours in the presence of ganglioside preparations in the culture medium. Figure 5 shows dose-response curves of the platelet-producing megakaryocyte formation to various ganglioside preparations. Ganglioside GDIa increased the number of total megakaryocytes dose-dependently (Fig. 5A) , and markedly stimulated formation of the platelet-producing megakaryocytes (Fig. 5B) . The ratio of the platelet-producing megakaryocytes to total megakaryocytes increased dose-dependently, and reached a plateau level at a concentration of 125jug GDla/ml (Fig. 5C ). On the other hand, ganglioside GM1 did not affect the number of total megakaryocytes even at higher concentrations, although it stimulated formation of the platelet-producing megakaryocytes. Thus, the ratio was increased dose-dependently by GM1, markedly to a concentration of 250 //g/ml and gradually at higher concentrations. Gangliosides GM2,GM3and GDlb had little effects on either the numberof total megakaryocytesor the ratio of the platelet-producing megakaryocytes to total megakaryocytes. Ganglioside mixture showed moderate effects on both the values, as comparedwith other ganglioside preparations (Fig. 5 ).
Ganglioside GDIa treated with neuraminidase did not increase the number of total megakaryocytes during incubation, although it still stimulated formation of the platelet-producing megakaryocytes. The activity of neuraminidase-treated GDIa was similar to that of nontreated ganglioside GM1, suggesting GDIa was converted to GM1 by neuraminidase treatment. On the other hand, treatment of ganglioside GM1with neuraminidase exerted no significant effect on the activity. .Dose responsiveness ofthe platelet-producing megakaryocyte formation tovarious gangliosides. Inthe presence ofganglioside GM1 (O),GDla (å ), GM2 (å¡), GDlb (A),GM3 (A)andbovine brain ganglioside mixture (GSM à"), the megakaryocyte-enriched bone marrow cell suspension was incubated for 12 hours. The number ofthe cells atthe start ofincubation: 26to70 megakaryocytes/chamber. An average of282 megakaryocytes was counted inseveral chambers for each incubation system. InGM1, GDla, GDlb and GSM, thepoints represent the mean values oftwo separate experiments, and the vertical bars represent the variation. Ganglioside GDIa (500^g/ml) Ganglioside GM1 ($00 /ig/ml) a; Platelet-producing megakaryocytes {% of total megakaryocytes). b; Total megakaryocytes/chamber (mean ±SE). The number of chambers examined is given in parentheses. Incubation; 12 hrs at 37°C.
Protease treatment exerted no significant effect on the activities of either ganglioside GDIa or GM1 (Table I) . The results suggest that the activities of ganglioside preparations GDIa and GM1 were not due to contaminating proteins or polypeptides.
DISCUSSION
Platelets are thought to be delineated within the cytoplasm of megakaryocytes by the demarcation membrane systems at the terminal stage of cytoplasmic maturation of the cells. Scanning electron microscopic studies revealed that extravascularly located megakaryocytes extended long cytoplasmic processes through bone marrow sinusoids in vivo (1, 9) . For the mechanismof platelet-shedding, some investigators believe that these processes subsequently develop segmental constrictions and separate into individual platelets, and thus platelet demarcation proceeds to completion within these processes (9, 10, 14, 17) . Others believe that these processes are not precursors to platelet production, but platelet demarcation is completed within the central cytoplasmic mass of the megakaryocytes (2, 9, 13 NaF and monoiodoacetic acid, markedly inhibited formation of the platelet-producing megakaryocytes, suggesting that the process is dependent on both aerobic and anaerobic energy producing systems.
Ganglioside GDIa increased the number of total megakaryocytes and the ratio of the platelet-producing cells to total megakaryocytes, while GM1 stimulated only the increase in the ratio. Since other gangliosides examined had little effect on either the number of total megakaryocytes or the ratio of the platelet-producing megakaryocytes to total megakaryocytes, it is conceivable that GDIa and GM1 characteristically play roles in the regulation of cell maturation in murine megakaryocytes.
The increase in the number of total megakaryocytes during incubation suggests the maturation of megakaryocytic progenitors, which initially could not be detected as the progenitors, into the recognizable mature megakaryocytes. The increase in the numberof platelet-producing megakaryocytes indicates the maturation of the existing mature megakaryocytes to the fully mature cells with fragmented cytoplasm. Ganglioside GDIa may be specifically incorporated into the plasma membraneof the progenitor cells and accelerate at least two steps of maturation, the cytoplasmic growth of the progenitors to megakaryocytes, and the subsequent step of demarcation membrane formation. By contrast, GM1maybe incorporated into mature megakaryocytes and stimulate the latter step, the formation of platelet demarcation membrane. The possibility cannot be ruled out that, however, ganglioside GDla in megakaryocytes might transformed into ganglioside GM1, and then GM1induce the latter step of the maturation. Further studies on possible incorporation of exogenous GDla and GM1into plasma membrane of the target cells will clarify the mechanism involved in maturationinduction by these ganglioside molecules. {Received for publication, November 7, 1989 and in revised form, February 6, 1990) 
